12:00 AM
 | 
Apr 29, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Anti-CCP IVD kit regulatory update

Theradiag said it received CE Mark approval for its anti- cyclic citrullinated peptide...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >